| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |